| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87a863132c68cf0f62015bbd5d05ab38 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-18 |
| filingDate |
2009-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d4a63e82887b11ebf40e4337ba26e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a62a5815871e82103d249dcbe00eed |
| publicationDate |
2021-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2805964-T3 |
| titleOfInvention |
Compositions of galactose alpha (1-3) galactose |
| abstract |
A method for producing a homogeneously alpha-galactosylated antibody preparation producing an alpha-galactosylated oligosaccharide structure comprising a terminal Gal-alpha (1,3) -Gal-beta (1-4) GlcNAc in an antibody wherein the method comprises : (a) mixing an antibody, an activated galactose, a divalent metal selected from the group consisting of Mn2 +, Ca2 + and Zn2 +, an alpha (1-3) galactosyltransferase, and a beta (1-4) galactosyltransferase in an aqueous medium within a single vessel for forming an aqueous reaction medium; and (b) maintaining said aqueous reaction medium at a pH of 5 to 10 at a temperature of from about 25 ° C to about 40 ° C for a period of time sufficient for said antibody to glycosylate. |
| priorityDate |
2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |